Here are four key notes:
1. Under the agreement, Smith & Nephew can distribute OrthAlign’s KneeAlign technology as part of its portfolio in 21 countries across Asia, Africa, the Middle East, Australia and New Zealand.
2. KneeAlign technology aims to provide both tibial and distal femoral precision alignment in a palm-sized, single-use device, providing real-time data.
3. The technology is intended for use during total knee arthroplasty procedures.
4. To date, KneeAlign has been used in approximately 40,000 TKA cases globally.
“From the region of the globe where the volume of knee replacement is growing rapidly, OrthAlign adds a critical enabling technology to complement Smith & Nephew’s industry leading knee brands such as JOURNEY II, LEGION AND GENESIS II,” said David Cook, director of knee reconstruction, APAC and emerging markets, at Smith & Nephew. “We believe this partnership will allow Smith & Nephew to provide further benefits to both healthcare professionals and the patients they serve in this evolving and dynamic geography.”
More articles on devices:
FDA schedules meeting to review Cartiva’s PMA for synthetic cartilage implant: 4 points
Zimmer Biomet investors to offer 11M+ shares of common stock: 5 takeaways
Stryker director sells 12k shares, soon after Sage Products acquisition & potential Moody’s downgrade: 7 points
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
